Diabetes Publish Ahead of Print published online ahead of print March 27, 2007 DOI: 10.2337/db06-1540
New ABCC8 mutations in Relapsing Neonatal Diabetes and Clinical Features
Martine Vaxillaire1,
Aurélie Dechaume1,
Kanetee Busiah2,7,
Hélène Cavé3,
Sabrina Pereira3,
Raphael Scharfmann2,4,
Guiomar Perez de Nanclares5,
Luis Castano5,
Philippe Froguel1,6,
Michel Polak and the SUR1-NDM Study Group2,4,7
1CNRS, 8090-Institute of Biology, Pasteur Institute, Lille, France
2Faculty of Medicine, René Descartes Paris 5 University, Paris, France
3Genetic Biochemistry, Robert Debré Hospital, Paris, France
4Inserm, EMI 0363, Necker Enfants Malades Hospital, Paris, France
5Endocrinology and Diabetes Research Group, Hospital de Cruces, Barakaldo, Bizkaia, Spain
6Genomic Medicine, Hammersmith Hospital, Imperial College, London, United Kingdom
7Department of Pediatric Endocrinology, Necker Enfants Malades Hospital, Paris, France
Correspondence:
martine.vaxillaire{at}good.ibl.fr
Key Words: ABCC8 ATP-sensitive potassium channel Diabetes Genetics Neonatal diabetes SUR1
Activating mutations in the ABCC8 gene that encodes the SUR1 regulatory subunit of the pancreatic islet ATP-sensitive potassium (KATP) channel cause both permanent and transient neonatal diabetes mellitus (NDM). Recently, we have described the novel mechanism where basal Mg-nucleotide-dependent stimulatory action of SUR1 on the KIR6.2 pore is increased. In our present study, we identified six new heterozygous ABCC8 mutations mainly in patients presenting the transient form of NDM (6/8), with a median duration of initial insulin therapy of 17 months (range 0.5-38). Most of these mutations map to key functional domains of SUR1. Whereas KIR6.2 mutations are a common cause of permanent NDM and in a few cases associate with the DEND syndrome, SUR1 mutations are more frequent in transient (52%) compared to permanent (14%) NDM cases screened for ABCC8 in our series. Although ketoacidosis is frequent at presentation, SUR1 mutations associate mainly with transient hyperglycemia with possible recurrence later in life. Half of the SUR1-NDM patients presented with de novo mutations. In some of the cases that are familial, diabetes is not always present in the adult carriers of SUR1 mutations supporting variability in their clinical expressivity that remains to be fully explained.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Polak, A. Dechaume, H. Cave, R. Nimri, H. Crosnier, V. Sulmont, M. de Kerdanet, R. Scharfmann, Y. Lebenthal, P. Froguel, et al.
Heterozygous Missense Mutations in the Insulin Gene Are Linked to Permanent Diabetes Appearing in the Neonatal Period or in Early Infancy: A Report From the French ND (Neonatal Diabetes) Study Group
Diabetes,
April 1, 2008;
57(4):
1115 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P.H. Shield, S. E. Flanagan, D. J. Mackay, L. W. Harries, P. Proks, C. Girard, F. M. Ashcroft, I. K. Temple, and S. Ellard
Mosaic Paternal Uniparental Isodisomy and an ABCC8 Gene Mutation in a Patient With Permanent Neonatal Diabetes and Hemihypertrophy
Diabetes,
January 1, 2008;
57(1):
255 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Polak
Neonatal Diabetes Mellitus: Insights for More Common Forms of Diabetes
J. Clin. Endocrinol. Metab.,
October 1, 2007;
92(10):
3774 - 3776.
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Diabetes Association.
|
|
| |
|